# Pictor Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pictor-labs

- Industry: Biotechnology
- Headquarters: Los Angeles, US
- Website: www.pictorlabs.ai
- Total disclosed funding: $28M
- Latest round: Series B (Jan 15, 2025)
- Investors on record: 5

## About

Founded in 2019 and based in California, US, Pictor Labs, Inc. is a digital pathology firm that is developing an AI-powered virtual staining platform to transform histopathology and accelerate clinical research in order to improve patient outcomes. Aydogan Ozcan and Yair Rivenson (CEO) are the co-founders of the company. In January 2025, Pictor Labs, Inc. raised an undisclosed amount from new investor LabCorp Ventures.

The firm is reimagining existing histopathology workflows, accelerating clinical and diagnostic results, and improving process sustainability. PictorLabs' approach produces a number of virtual stains from a single unstained tissue sample, removing the need for chemical staining and enabling recurrent biomarker testing without the need for multiple tissue samples. The organisation plans to use the November 2022 funding to further develop histopathology, simplify lab workflows, and increase the drug discovery rate.

The company plans to use the January 2025 funding to accelerate the development and adoption of PictorLabs' virtual staining technology.

## Funding rounds

- Series B, Jan 15, 2025 — LabCorp Ventures
- Series B, Aug 6, 2024, $21M — Insight Partners, M Ventures
- Series A, May 26, 2022, $7.6M — Koc Holding A.S., M Ventures, Soft Computer Consultants, Inc.

## Investors

- Koc Holding A.S. — Series A
- M Ventures (https://capitalatlas.ai/funds/m-ventures) — Series A, Series B
- Soft Computer Consultants, Inc. — Series A
- Insight Partners (https://capitalatlas.ai/funds/insight-partners) — Series B
- LabCorp Ventures (https://capitalatlas.ai/funds/labcorp-ventures) — Series B